Skip to content

Acupuncture for the Treatment of Vulvodynia

Acupuncture for the Treatment of Vulvodynia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02197429
Enrollment
36
Registered
2014-07-22
Start date
2012-02-29
Completion date
2012-12-31
Last updated
2014-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspareunia, Female Sexual Dysfunction Due to Physical Condition, Pain, Vulvar Vestibulitis, Vulvodynia

Keywords

Vulvodynia, Acupuncture, Provoked Vestibulodynia, Vulvar Vestibulitis, Vulvar Pain, Dyspareunia, Female Sexual Function

Brief summary

A randomized controlled pilot study was conducted to evaluate the effect of an acupuncture protocol for the treatment of vulvodynia. Hypotheses: 1. Acupuncture reduces vulvar pain and dyspareunia in women with vulvodynia. 2. Acupuncture increases sexual function in women with vulvodynia.

Interventions

OTHERAcupuncture

Sponsors

Schlaeger, Judith M., CNM, LAc, PhD
Lead SponsorINDIV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Previously diagnosed with either generalized vulvodynia, localized vestibulodynia, or both * Provoked vulvodynia * Unprovoked vulvodynia * Women between 18 years of age and menopause

Exclusion criteria

* Pregnancy * Menopause * Interstitial cystitis * Irritable bowel syndrome * Untreated vaginitis * Cervicitis * Pelvic inflammatory disease * Diagnosed with other pelvic pathology causing pain * Concomitantly receiving physical therapy * Concomitantly receiving biofeedback, * Concomitantly receiving massage * Concomitantly receiving additional acupuncture.

Design outcomes

Primary

MeasureTime frameDescription
vulvar painBaseline and 5 weeksChange from baseline in The Short Form McGill Pain Questionnaire at 5 weeks

Secondary

MeasureTime frameDescription
DyspareuniaBaseline and 5 weeksChange from baseline in the pain subscale of the Female Sexual Function Index at 5 weeks

Other

MeasureTime frameDescription
Female sexual functionBaseline and 5 weeksChange from baseline in the total score of the Female Sexual Function Index at 5 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026